DeNovo Sciences
Innovative single-cell analysis solutions for advancing life sciences research and diagnostics.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | $7.9m | Early VC | |
| Total Funding | 000k | ||
Related Content
Denovo Sciences specializes in providing cutting-edge single-cell analysis solutions that empower researchers and clinicians in the life sciences sector. The company operates in the biotechnology and healthcare markets, offering advanced tools and technologies that enable detailed cellular analysis. Denovo Sciences serves a diverse clientele, including academic institutions, pharmaceutical companies, and diagnostic labs. The business model revolves around the sale of proprietary single-cell analysis instruments and consumables, as well as offering technical support and maintenance services. Revenue is generated through direct sales, service contracts, and ongoing supply of consumables.
Keywords: single-cell analysis, biotechnology, healthcare, diagnostics, research tools, pharmaceutical, academic institutions, proprietary instruments, technical support, consumables.